Endometrial Stromal Sarcoma

Definition

Endometrial stromal sarcoma is a rare type of cancer that originates in the connective tissue cells of the endometrium, which is the lining of the uterus. It is characterized by abnormal and uncontrolled growth of these cells, which can invade surrounding tissues and spread to other parts of the body.

Added:January 10, 2025

Updated:January 10, 2025

Overview

Endometrial stromal sarcoma (ESS) is a rare form of uterine cancer that arises from the stromal tissue of the endometrium. Unlike more common types of uterine cancer that originate in the glandular tissue, ESS develops in the connective tissue that supports the endometrium. It accounts for less than 1% of all uterine cancers, making it a rare but significant condition.

Key Information

ESS is classified into different types based on the growth rate and behavior of the cancer cells: low-grade and high-grade. Low-grade ESS tends to grow slowly and may recur after treatment, while high-grade ESS grows rapidly and is more aggressive. The exact cause of ESS is unknown, but it is believed to be associated with genetic mutations and hormonal factors.

Clinical Significance

The medical importance of ESS lies in its rarity and the challenges it presents in diagnosis and treatment. Symptoms may include abnormal uterine bleeding, pelvic pain, and a mass in the pelvis. Due to its uncommon nature, it is often diagnosed at a later stage, which can complicate treatment. Early detection and accurate diagnosis are crucial for effective management.

Treatment & Management

Treatment options for ESS typically involve surgery to remove the tumor, often including a hysterectomy. Depending on the stage and grade of the cancer, additional treatments such as hormone therapy, radiation, or chemotherapy may be recommended. Ongoing follow-up care is essential to monitor for recurrence and manage any side effects of treatment.

Patient Resources

Patients diagnosed with ESS can access various resources for support and education. Organizations like the American Cancer Society and the National Cancer Institute offer comprehensive information and support networks. Joining support groups can also provide emotional and practical support from others who have experienced similar challenges.

Frequently Asked Questions

What are the symptoms of endometrial stromal sarcoma?

Common symptoms include abnormal uterine bleeding, pelvic pain, and a palpable mass in the pelvic area.

How is endometrial stromal sarcoma diagnosed?

Diagnosis typically involves imaging tests such as ultrasound or MRI, followed by a biopsy to confirm the presence of cancerous cells.

What are the treatment options for ESS?

Treatment usually involves surgery, and may also include hormone therapy, radiation, or chemotherapy depending on the specific case.

Can endometrial stromal sarcoma recur after treatment?

Yes, especially in low-grade cases, ESS can recur after initial treatment, necessitating regular follow-up care.

Related Terms

Acute Lymphoblastic Leukemia (ALL)

Acute Lymphoblastic Leukemia (ALL) is a rare type of cancer characterized by the rapid production of abnormal white blood cells in the bone marrow. These cells impede the production of normal blood cells, triggering symptoms like fatigue, fever, and bleeding. ALL is most common in children but can also occur in adults. Treatment often involves chemotherapy, radiation, targeted therapy, or stem cell transplant.

Anal cancer

Anal cancer is a rare type of malignancy arising from the anal canal or rectum. It starts when healthy cells in or around the anus change and grow out of control, forming a mass. Risk factors include increasing age, history of HPV infections, and smoking. Symptoms may include rectal bleeding, pain, or changes in bowel movements. Treatment often involves chemotherapy, radiation, or surgery.

Angiosarcoma: Unveiling the Malignancy

Angiosarcoma is a rare, malignant tumor that originates from endothelial cells, the cells that line the interior surface of blood vessels. It can occur anywhere in the body, but is most commonly found in the skin, breast, liver, spleen, and deep tissue. Due to its aggressive nature, it often leads to a poor prognosis. This tumor presents unique challenges due to its high recurrence rate and resistance to treatment.